1. Canada Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
Glow Lifetech Corp.

Glow Lifetech Corp.

GLOW.CN
Glow Lifetech Corp.CA flagCanadian Securities Exchange
0.05
CAD
- -
- -
9.61MMarket Cap
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
- -
- -
- -
- -
- -
0.01
- -
0.01
Basic EPS, GAAP
- -
- -
-0.24
-0.04
-0.03
-0.03
- -
- -
Free Cash Flow per Basic Share
- -
- -
-0.08
-0.02
-0.01
-0.02
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
-0.02
-0.02
- -
-0.04
-0.08
-0.04
- -
-0.02
Tangible Book Value per Share
- -
-0.01
0.03
-0.01
-0.03
0.02
- -
0.01
Basic Weighted Avg Shares
56
56
48
57
57
89
- -
170
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
1
2
2
Operating Margin (%)
- -
- -
- -
- -
-3,610.79
-183.31
-35.44
-35.44
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
- -
- -
-11
-2
-2
-3
-1
-1
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
-3,617.4
-317.79
-30.09
-30.09
Working Capital
- -
- -
1
-1
-2
1
1
1
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
- -
- -
3
1
-1
3
3
3
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
21.59
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -
- -
- -

Capital Structure

FRC

•

in mil. unless spec.
Jun'25
Sep'25
Dec'25
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
170
171
181
Market Capitalization
7
9
10

Working Capital

FRC

•

in mil. unless spec.
Jun'25
Sep'25
Dec'25
Total Current Assets
3
3
2
Cash, Cash Equivalents & STI
1
1
1
Accounts Receivable, Net
- -
1
- -
Inventories
- -
- -
- -
Total Current Liabilities
1
1
1
Payables & Accruals
1
1
1
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
-358.27%
5.42%
Free Cash Flow
- -
3,847.48%
-91.29%
Net Income, GAAP
- -
1,430.81%
-76.75%
Sales/Revenue/Turnover
- -
- -
145.6%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
1
2025
- -
- -
1
1
2

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
-0.01
-0.01
-0.01
- -
-0.03
2024
- -
- -
-0.01
- -
-0.03
2025
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
Roberto Paolo Carducci
Sector
Healthcare
Industry
Biotechnology
Address
65 International Boulevard Toronto ON Canada M9W 6L9
IPO Date
Mar 15, 2021
Website
glowlifetech.com
Similar Companies
ZIOPHARM Oncology, Inc. (ZIOP)
IGC Pharma, Inc. (IGC)
Vaxart, Inc. (VXRT)
Jiangxi Fushine Pharmaceutical Co., Ltd. (300497.SZ)
Cambium Bio Limited (CMB.AX)
Oramed Pharmaceuticals Inc. (ORMP)
Business
Glow Lifetech Corp. (CSE: GLOW) is a Canadian biotechnology company that develops and commercializes high-performance, water-soluble natural ingredients for functional foods, beverages, supplements and personal care products using its proprietary, plant-based MyCell delivery system technology. The company produces water-soluble cannabinoids, vitamins, botanicals and customized blends in liquid format; powder-based capsules; precision-dosed market-ready products; and fusions of nutraceuticals with cannabis and hemp-derived ingredients, including exclusive North American rights for micellization technology applied to curcumin, vitamin K, iron and certain cannabis extracts, marketed under the MOD and .decimal brands. Founded in 2019 as a subsidiary of Scryb Inc. and headquartered at 65 International Blvd., Suite 206, Toronto, Ontario, Glow Lifetech operates primarily in Canada with expanding national distribution targeting retailers and consumers in the natural health and cannabis sectors. Recent developments include expansion of MOD and .decimal brands into over 60 One Plant stores across Ontario and Saskatchewan in October 2025; first shipments and 10 product listings in Saskatchewan marking entry into Western Canada; launch in 100+ FIKA Company stores in Ontario in August 2025; commissioning of a new automated bottling line and CBG-based product launch in July 2025; achievement of debt-free status in November 2025 after reducing over $1.4 million in debt since Q3 2024; closure of a non-brokered private placement and debt settlement in January 2025; and record Q3 2025 financial results with 193% year-over-year revenue growth and first positive cash flow from operations.